Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Restatement of Net Asset Value(s)

10th Feb 2026 12:02

RNS Number : 4572S
Intl. Biotechnology Trust PLC
10 February 2026
 

10 February 2026

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

 Restatement of Net Asset Value(s)

 

The Board of International Biotechnology Trust plc (the "Company") announces that, due to an administrative error relating to the non-accrual of the Company's most recent interim dividend, the Company's unaudited cum income net asset value ("NAV") per share has been restated for the following dates, as follows:

 

Date

Published Cum Income NAV per Share

Revised Cum Income NAV per Share

29/12/2025

1021.50

1005.87

30/12/2025

1016.30

1000.69

31/12/2025

1024.00

1008.35

02/01/2026

1013.20

997.59

05/01/2026

998.07

982.44

06/01/2026

1004.10

988.51

07/01/2026

1035.70

1020.10

08/01/2026

1025.30

1009.67

09/01/2026

1032.20

1016.53

12/01/2026

1010.90

995.29

13/01/2026

1007.40

991.72

14/01/2026

1031.00

1015.36

15/01/2026

1021.10

1005.51

16/01/2026

1013.60

997.96

19/01/2026

1009.70

994.04

 

As a result, the Company's service providers have implemented corrective measures and enhanced their procedures.

 

Enquiries:

Natalia de Sousa

Schroder Investment Management Limited

Tel: 020 7658 6000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRSFFFESEMSESE

Related Shares:

Int.biotech.
FTSE 100 Latest
Value10,402.44
Change-69.67